Mucormycosis (black fungus) in COVID-19 patients-Will it be another matter of concern in the midst of the COVID-19 flare-up in Bangladesh?

Md Tanvir Rahman; Md Golzar Hossain; A M M Taufiquer Rahman; A K M Moyeenul Huq; Shahnur Farzana; K H M Nazmul Hussain Nazir

doi:10.5455/javar.2021.h524

Mucormycosis (black fungus) in COVID-19 patients-Will it be another matter of concern in the midst of the COVID-19 flare-up in Bangladesh?

J Adv Vet Anim Res. 2021 Jul 9;8(3):367-369. doi: 10.5455/javar.2021.h524. eCollection 2021 Sep.

Authors

Md Tanvir Rahman¹, Md Golzar Hossain¹, A M M Taufiquer Rahman², A K M Moyeenul Huq³, Shahnur Farzana⁴, K H M Nazmul Hussain Nazir¹

Affiliations

¹ Department of Microbiology and Hygiene, Faculty of Veterinary Science, Bangladesh Agricultural University, Mymensingh-2202, Bangladesh.
² Naogaon District Hospital, Naogaon-6500, Bangladesh.
³ Department of Pharmacy, School of Medicine, University of Asia Pacific, Dhaka-1205, Bangladesh.
⁴ Department of Biochemistry, Community Based Medical College, Mymensingh-2200, Bangladesh.

Abstract

Many countries of the world have been combating the new variant of severe acute respiratory syndrome coronavirus 2. Black fungus is an opportunistic foe that may cause fatal infection in immunocompromised and steroid-treated coronavirus disease 2019 (COVID-19) patients. The COVID-19 associated mucormycosis (CAM) is now a serious concern throughout the world, including many Asian countries. Therefore, along with early and accurate diagnostic facilities, special care, and prompt, but coordinated approach are recommended to combat the CAM in patients.

Keywords: COVID-19; Risk factors; mucormycosis; steroid.

Publication types

Editorial